Woodline Partners’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75,000
Closed -$6K 936
2022
Q2
$6K Hold
75,000
﹤0.01% 742
2022
Q1
$12K Hold
75,000
﹤0.01% 674
2021
Q4
$41K Hold
75,000
﹤0.01% 641
2021
Q3
$44K Hold
75,000
﹤0.01% 622
2021
Q2
$64K Hold
75,000
﹤0.01% 532
2021
Q1
$44K Buy
+75,000
New +$46K ﹤0.01% 417

Other funds holding SHACW

Woodline Partners's SHACW Position: Q3 2022 in Review

Woodline Partners sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q3 2022, closing a stake of 75,000 shares — an estimated $6K sold.

Woodline Partners first reported a position in SHACW in Q1 2021 and held it in 6 quarters. The position peaked at $64K in Q2 2021. 53 funds tracked by Wall St. Rank hold SHACW as of Q3 2022.

  • Woodline Partners reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q3 2022 after selling out during the quarter.
  • Woodline Partners sold 75,000 SCP & CO Healthcare Acquisition Company Warrant shares in Q3 2022, an estimated $6K.
  • Woodline Partners first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 6 quarters.
  • Woodline Partners's SCP & CO Healthcare Acquisition Company Warrant position peaked at $64K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q3 2022.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.